NASDAQ : SOPH
SOPHiA GENETICS SA — Key statistics
Healthcare · Health Information Services · Switzerland
Last price 7.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 678.47M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 649.53M |
| Enterprise Value | 603.69M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 85.13M |
| Shares Outstanding | 85.13M |
| Shares Change (YoY) | +4.40% |
| Shares Change (QoQ) | +3.80% |
| Owned by Insiders (%) | 8.40% |
| Owned by Institutions (%) | 47.76% |
| Float | 65.47M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.54 |
| Forward PS | 6.09 |
| PB Ratio | 7.81 |
| P/TBV Ratio | 13.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 7.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.69 |
| Quick Ratio | 2.38 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.13 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -101.22% |
| Return on Assets (ROA) | -24.52% |
| Return on Invested Capital (ROIC) | -32.29% |
| Return on Capital Employed (ROCE) | -50.07% |
| Weighted Average Cost of Capital (WACC) | 9.40% |
| Revenue Per Employee | $207,631 |
| Profits Per Employee | -$194,887 |
| Employee Count | 415 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 4.32 |
Taxes
| Measure | Value |
|---|
| Income Tax | 578,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +68.06% |
| 50-Day Moving Average | 7.87 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 51.58 |
| Average Volume (20 Days) | 558,155 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.00M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 1.17% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 1.35 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 86.17M |
| Gross Profit | 57.41M |
| Operating Income | -73.74M |
| Pretax Income | -80.30M |
| Net Income | -80.88M |
| EBITDA | -71.75M |
| EBIT | -73.74M |
| Loss Per Share | -$1.16 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 107.67M |
| Total Debt | 61.83M |
| Net Cash | 45.84M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 83.12M |
| Book Value Per Share | 0.98 |
| Working Capital | 86.21M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -39.74M |
| Capital Expenditures | -1.47M |
| Depreciation & Amortization | 2.00M |
| Net Borrowing | -2.18M |
| Free Cash Flow | -41.21M |
| FCF Per Share | -$0.48 |
Margins
| Measure | Value |
|---|
| Gross Margin | 66.63% |
| Operating Margin | -85.58% |
| Pretax Margin | -93.19% |
| Profit Margin | -93.86% |
| EBITDA Margin | -83.26% |
| EBIT Margin | -85.58% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.40% |
| Shareholder Yield | -4.40% |
| Earnings Yield | -15.20% |
| FCF Yield | -6.34% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $9.75 |
| Price Target Difference | 27.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 25.92% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.61 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |